Hereditary sensory and autonomic neuropathy (HSAN) encompasses a group of rare genetic disorders that cause progressive degeneration of specific peripheral nerve populations. Unlike neurodegenerative diseases affecting the brain, HSAN selectively destroys sensory neurons responsible for pain and temperature sensation, along with autonomic neurons controlling vital functions like heart rate, breathing, and digestion.[@j2019] Patients gradually lose protective pain responses, leading to unnoticed injuries, infections, and often limb amputations, while autonomic dysfunction can trigger life-threatening cardiac and respiratory complications.
HSAN provides researchers with unique insights into selective neuronal vulnerability—the puzzle of why certain nerve cells succumb to disease while neighboring neurons remain unaffected. The eight recognized HSAN subtypes result from mutations in distinct genes including SPTLC1, NTRK1, WNK1, and others, each disrupting different cellular pathways from lipid metabolism to nerve growth factor signaling.[@k2006] These genetic variants create natural experiments for understanding how diverse molecular mechanisms can produce similar patterns of neurodegeneration, offering parallels to more common conditions like diabetic neuropathy and age-related sensory loss.[@a2022]
Hereditary sensory and autonomic neuropathy (HSAN) encompasses a group of rare genetic disorders that cause progressive degeneration of specific peripheral nerve populations. Unlike neurodegenerative diseases affecting the brain, HSAN selectively destroys sensory neurons responsible for pain and temperature sensation, along with autonomic neurons controlling vital functions like heart rate, breathing, and digestion.[@j2019] Patients gradually lose protective pain responses, leading to unnoticed injuries, infections, and often limb amputations, while autonomic dysfunction can trigger life-threatening cardiac and respiratory complications.
HSAN provides researchers with unique insights into selective neuronal vulnerability—the puzzle of why certain nerve cells succumb to disease while neighboring neurons remain unaffected. The eight recognized HSAN subtypes result from mutations in distinct genes including SPTLC1, NTRK1, WNK1, and others, each disrupting different cellular pathways from lipid metabolism to nerve growth factor signaling.[@k2006] These genetic variants create natural experiments for understanding how diverse molecular mechanisms can produce similar patterns of neurodegeneration, offering parallels to more common conditions like diabetic neuropathy and age-related sensory loss.[@a2022]
The study of HSAN has revealed critical roles for sphingolipid biosynthesis, neurotrophic factor signaling, and ion channel function in maintaining peripheral nerve health. Understanding these disease mechanisms may unlock therapeutic strategies not only for HSAN patients but also for the millions affected by acquired forms of peripheral neuropathy.
Hereditary Sensory And Autonomic Neuropathy (Hsan) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Hereditary Sensory and Autonomic Neuropathies (HSANs), also known as hereditary sensory neuropathies, are a group of rare genetic disorders characterized by progressive loss of sensory and autonomic nerve function. These disorders are caused by mutations in genes essential for the development, maintenance, and function of sensory and autonomic [neurons](/entities/neurons)[^1].
HSANs are classified into multiple subtypes (HSAN Type I through Type VIII), each associated with different genetic causes, clinical presentations, and inheritance patterns. The disorders range from mild to severe, with some forms being degenerative and others remaining stable over time[^2].
Hereditary sensory and autonomic neuropathies are classified into eight distinct types based on their genetic underpinnings and clinical manifestations. HSAN Type I represents the most common form and follows an autosomal dominant inheritance pattern, with mutations occurring in the SPTLC1 gene (designated as HSAN1A) or the SPTLC2 gene (classified as HSAN1B). This condition typically manifests during adolescence to early adulthood and is characterized by progressive loss of pain and temperature sensation, which frequently leads to the development of foot ulcers and may necessitate amputations due to unrecognized injuries.
In contrast, HSAN Type II follows an autosomal recessive inheritance pattern and is associated with mutations in the WNK1 or NGF genes. This form presents much earlier in life, typically during early childhood, and is distinguished by severe sensory loss accompanied by significant autonomic dysfunction. The early onset and severity of symptoms in HSAN2 reflect the critical roles these genes play in sensory and autonomic nervous system development.
HSAN Type III, also known as Riley-Day Syndrome, is caused by mutations in the ELP1 gene, which was previously designated as IKBKAP. This autosomal recessive condition has distinctive clinical features that are comprehensively detailed on the Familial Dysautonomia page due to the complexity and specificity of its presentation.
HSAN Type IV, another autosomal recessive disorder, results from mutations in the TRPV1 gene, formerly known as NTRK1. This condition is particularly severe as it presents with congenital insensitivity to pain, anhidrosis (inability to sweat), and intellectual disability. The combination of these features creates significant challenges in patient management and highlights the crucial role of the TRPV1 gene in pain perception and thermoregulation.
HSAN Type V demonstrates genetic heterogeneity, as it can be caused by mutations in multiple genes including NGF, SCN9A, or SCN11A, and can follow either autosomal recessive or dominant inheritance patterns depending on the specific genetic variant involved. This type is characterized by selective loss of pain perception, which distinguishes it from other forms that may have broader sensory deficits.
The more recently identified HSAN Type VI is an autosomal recessive condition associated with mutations in voltage-gated sodium channel genes, specifically SCN9A, SCN10A, or SCN11A. Patients with this type experience severe pain insensitivity and commonly develop gastrointestinal issues, reflecting the important role these sodium channels play in both peripheral pain sensation and enteric nervous system function.
HSAN Type VII follows an autosomal dominant inheritance pattern and is specifically linked to mutations in the SCN11A gene. This condition shares the pain insensitivity feature with other types but is additionally characterized by gastrointestinal dysmotility, which can significantly impact patient quality of life and requires specialized management approaches.
The most recently described form, HSAN Type VIII, is caused by mutations in the P2RX7 gene and follows an autosomal recessive inheritance pattern. This type presents a unique constellation of features including developmental delay, pain insensitivity, and argyria (a bluish-gray discoloration of the skin), making it clinically distinct from other HSAN subtypes and highlighting the diverse roles of purinergic signaling in nervous system development and function.
Despite different genetic causes, HSANs share common pathological features:
The clinical presentation of hereditary sensory and autonomic neuropathies is characterized by a distinctive constellation of sensory and autonomic deficits that reflect the underlying damage to peripheral nerve fibers. The most prominent feature is a profound loss of pain perception, which serves as the hallmark of these conditions and often leads to the most serious complications. This is typically accompanied by temperature insensitivity, rendering patients unable to detect potentially harmful hot or cold stimuli. While touch perception may also be compromised, it is generally less severely affected than pain and temperature sensation, creating a characteristic pattern of sensory loss that reflects the selective vulnerability of small-diameter nerve fibers.
The autonomic nervous system manifestations add another layer of complexity to the clinical picture. Orthostatic hypotension frequently develops due to blood pressure dysregulation, while gastrointestinal dysfunction commonly presents as dysphagia and gastroparesis, significantly impacting nutritional status and quality of life. In addition to these features, patients often experience sweating abnormalities that may manifest as either anhidrosis or hyperhidrosis, depending on the specific subtype and affected nerve populations. Urinary dysfunction further compounds the autonomic symptoms, presenting as either incontinence or retention that requires ongoing medical management.
The sensory deficits directly contribute to a range of associated complications that define much of the long-term morbidity in these conditions. The inability to perceive pain leads to painless injuries that progress to chronic ulcerations, as patients fail to recognize and protect damaged tissues. This explains why autoamputation of fingers and toes can occur without the patient experiencing distress, representing one of the most dramatic manifestations of severe sensory loss. The lack of protective pain sensation also contributes to the development of joint deformities, particularly Charcot arthropathy, where repeated trauma to insensate joints leads to progressive structural damage. Certain subtypes of hereditary sensory and autonomic neuropathy are further characterized by developmental delays and cognitive impairment, with HSAN4 being particularly notable for these additional neurological features that extend beyond the peripheral nervous system involvement.
The clinical presentation of hereditary sensory and autonomic neuropathy is characterized by a constellation of progressive neurological deficits affecting both sensory and autonomic functions. The most prominent and defining feature is the profound loss of pain perception, which often serves as the initial presenting symptom and remains the most debilitating aspect throughout disease progression. This is closely accompanied by temperature insensitivity, manifesting as a complete inability to feel hot or cold sensations, which creates significant safety concerns for affected individuals. While touch perception is also compromised, it tends to be less severely affected compared to pain and temperature sensation, creating a characteristic pattern of selective sensory loss. Additionally, patients frequently develop proprioceptive deficits, leading to considerable difficulty with position sense and spatial awareness, which further compounds their functional limitations.
The autonomic nervous system dysfunction presents as a complex array of manifestations that significantly impact quality of life and overall health outcomes. Orthostatic hypotension represents one of the most common and clinically significant features, resulting from blood pressure dysregulation that can cause severe postural symptoms and limit daily activities. Gastrointestinal dysfunction is equally problematic, typically presenting as dysphagia and gastroparesis, which can lead to nutritional complications and aspiration risks. In addition to these digestive issues, patients commonly experience sweating abnormalities that may manifest as either complete absence of sweating (anhidrosis) or excessive sweating (hyperhidrosis), both of which contribute to temperature regulation difficulties. Furthermore, urinary dysfunction frequently develops, presenting as either incontinence or urinary retention, requiring careful monitoring and often necessitating specialized urological management.
The sensory and autonomic deficits give rise to several devastating secondary complications that often define the long-term prognosis. Painless ulcerations develop as a direct consequence of the inability to perceive injury, leading to chronic wounds that are difficult to heal and prone to infection. This explains why patients may experience autoamputation, the spontaneous loss of fingers or toes without any associated pain sensation, which can occur gradually and go unnoticed until significant tissue loss has occurred. The lack of protective sensation also predisposes patients to joint deformities, particularly Charcot arthropathy, where repetitive trauma and inadequate joint protection result in progressive bone and joint destruction. In certain subtypes of the condition, additional neurological features emerge, including developmental delays that can affect motor and cognitive milestones during childhood. This is further supported by the observation that specific forms, particularly HSAN4, are associated with cognitive impairment that can range from mild learning difficulties to more significant intellectual disability, adding another layer of complexity to the clinical management of these patients.
Hereditary sensory and autonomic neuropathy represents a very rare group of disorders, with prevalence estimates ranging from 1 in 100,000 to 1 in 1,000,000 individuals in the general population. The inheritance patterns of these conditions vary significantly depending on the specific type, with some forms following autosomal dominant transmission while others exhibit autosomal recessive inheritance.
The distribution of HSAN subtypes shows notable ethnic and population-specific variations that reflect underlying genetic founder effects and consanguinity patterns. HSAN1A demonstrates a higher frequency in European populations, suggesting possible founder mutations or genetic drift within these ancestral groups. In contrast, HSAN4 occurs more commonly in families with consanguineous marriages, which is consistent with its autosomal recessive inheritance pattern where affected individuals must inherit mutated copies of the gene from both parents. This explains why HSAN4 is more frequently observed in populations where marriage between relatives is culturally accepted, as the probability of inheriting identical recessive alleles increases substantially in such family structures.
Hereditary sensory and autonomic neuropathies represent a group of very rare disorders, with prevalence estimates ranging from 1 in 100,000 to 1 in 1,000,000 individuals in the general population. The inheritance patterns of these conditions vary significantly depending on the specific type, with some forms following autosomal dominant transmission while others exhibit autosomal recessive inheritance.
The distribution of HSAN subtypes shows notable variation across different ethnic populations and geographical regions. HSAN1A demonstrates a higher prevalence in European populations compared to other ethnic groups. In contrast, HSAN4 is more frequently observed in consanguineous families, where the increased likelihood of inheriting two copies of the same recessive allele from related parents explains the higher occurrence of this particular subtype in communities with higher rates of consanguineous marriages. This pattern of ethnic and familial clustering reflects the underlying genetic architecture of these disorders and highlights the importance of family history and population background in clinical diagnosis and genetic counseling.
The study of Hereditary Sensory And Autonomic Neuropathy (Hsan) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
This section highlights recent publications relevant to this disease.
A comprehensive study published in the American Journal of Medical Genetics Part A in April 2026 provided important insights through clinical and genetic characterization of hereditary sensory and autonomic neuropathy type IV in a consanguineous population, identifying novel NTRK1 variants and expanding the phenotypic spectrum. This genetic analysis is further supported by research examining the broader diagnostic applications of skin biopsies, as detailed in a February 2026 review in Pediatric Dermatology that explored pediatric conditions for which skin biopsies of clinically normal skin have diagnostic yield, providing valuable guidance for pediatric dermatologists.
In addition to genetic discoveries, recent research has focused on specific clinical presentations and diagnostic challenges. A case report published in the European Journal of Anaesthesiology in March 2026 examined congenital insensitivity to pain with anhidrosis, highlighting the complex anesthetic considerations for these patients. This clinical focus is complemented by orthopedic research published simultaneously in the Journal of Pediatric Orthopedics, which addressed the challenges and functional outcomes associated with type IV hereditary sensory and autonomic neuropathy, providing crucial insights for managing the orthopedic complications that commonly arise in these patients.
The cardiac manifestations of hereditary neuropathies have also received significant attention, as demonstrated by research published in Amyloid in March 2026 that investigated early cardiac sympathetic denervation in hereditary transthyretin amyloidosis. This study utilized (123)I-metaiodobenzylguanidine imaging findings and established important correlations with skin biopsy results, further emphasizing the multi-system nature of these hereditary conditions and the importance of comprehensive diagnostic approaches.
[^1]: [Reference missing - citation needed]